Comparison of Intraoperative Blood Product Use During Heart Transplantation in Patients Bridged with Impella 5.5 versus Durable Left Ventricular Assist Devices
- 6 May 2024
- journal article
- research article
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (11) , 2567-2575
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized TrialJAMA, 2022
- Left ventricular assist device implantation via lateral thoracotomy: A systematic review and meta-analysisThe Journal of Heart and Lung Transplantation, 2022
- Effects of the UNOS Allocation Policy Change on Impella Use as Bridge in Heart TransplantThe Journal of Heart and Lung Transplantation, 2021
- Effect of Blood Product Transfusion on Perioperative Outcomes After Heart TransplantationJournal of Cardiothoracic and Vascular Anesthesia, 2021
- INTERMACS profiles and outcomes of ambulatory advanced heart failure patients: A report from the REVIVAL RegistryThe Journal of Heart and Lung Transplantation, 2020
- Complications of Temporary Percutaneous Mechanical Circulatory Support for Cardiogenic Shock: An Appraisal of Contemporary LiteratureCardiology and Therapy, 2019
- The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report — 2019; focus theme: Donor and recipient size matchThe Journal of Heart and Lung Transplantation, 2019
- Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantationThe Journal of Heart and Lung Transplantation, 2013
- Reoperative Sternotomy Is Associated With Increased Mortality After Heart TransplantationThe Annals of Thoracic Surgery, 2012
- Increased Incidence of Gastrointestinal Bleeding Following Implantation of the HeartMate II LVADJournal of Cardiac Surgery, 2010